Market Research Logo

Incyte Corporation - Product Pipeline Review - 2016

Incyte Corporation - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Incyte Corporation - Product Pipeline Review - 2016’, provides an overview of the Incyte Corporation’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Incyte Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Incyte Corporation
  • The report provides overview of Incyte Corporation including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Incyte Corporation’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Incyte Corporation’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Incyte Corporation’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Incyte Corporation
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Incyte Corporation’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Incyte Corporation Snapshot
Incyte Corporation Overview
Key Information
Key Facts
Incyte Corporation - Research and Development Overview
Key Therapeutic Areas
Incyte Corporation - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Incyte Corporation - Pipeline Products Glance
Incyte Corporation - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Incyte Corporation - Early Stage Pipeline Products
IND/CTA Filed Products/Combination Treatment Modalities
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Incyte Corporation - Drug Profiles
(INCB-039110 + INCB-040093)
Product Description
Mechanism of Action
R&D Progress
epacadostat
Product Description
Mechanism of Action
R&D Progress
INCB-40093
Product Description
Mechanism of Action
R&D Progress
itacitinib adipate
Product Description
Mechanism of Action
R&D Progress
ruxolitinib phosphate
Product Description
Mechanism of Action
R&D Progress
INCB-50465
Product Description
Mechanism of Action
R&D Progress
INCB-52793
Product Description
Mechanism of Action
R&D Progress
INCB-53914
Product Description
Mechanism of Action
R&D Progress
INCB-54329
Product Description
Mechanism of Action
R&D Progress
INCB-54828
Product Description
Mechanism of Action
R&D Progress
INCB-59872
Product Description
Mechanism of Action
R&D Progress
SHR-1210
Product Description
Mechanism of Action
R&D Progress
INCAGN-1876
Product Description
Mechanism of Action
R&D Progress
INCAGN-1949
Product Description
Mechanism of Action
R&D Progress
INCB-57643
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody to Inhibit LAG3 for Oncology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody to Inhibit TIM3 for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Chronic Inflammation
Product Description
Mechanism of Action
R&D Progress
Incyte Corporation - Pipeline Analysis
Incyte Corporation - Pipeline Products by Target
Incyte Corporation - Pipeline Products by Route of Administration
Incyte Corporation - Pipeline Products by Molecule Type
Incyte Corporation - Pipeline Products by Mechanism of Action
Incyte Corporation - Recent Pipeline Updates
Incyte Corporation - Dormant Projects
Incyte Corporation - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
aderbasib
INCB-047986
itacitinib adipate
ruxolitinib phosphate
Incyte Corporation - Company Statement
Incyte Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Incyte Corporation, Key Information
Incyte Corporation, Key Facts
Incyte Corporation - Pipeline by Indication, 2016
Incyte Corporation - Pipeline by Stage of Development, 2016
Incyte Corporation - Monotherapy Products in Pipeline, 2016
Incyte Corporation - Combination Treatment Modalities in Pipeline, 2016
Incyte Corporation - Partnered Products in Pipeline, 2016
Incyte Corporation - Partnered Products/ Combination Treatment Modalities, 2016
Incyte Corporation - Out-Licensed Products in Pipeline, 2016
Incyte Corporation - Out-Licensed Products/ Combination Treatment Modalities, 2016
Incyte Corporation - Phase II, 2016
Incyte Corporation - Phase I, 2016
Incyte Corporation - IND/CTA Filed, 2016
Incyte Corporation - Preclinical, 2016
Incyte Corporation - Discovery, 2016
Incyte Corporation - Pipeline by Target, 2016
Incyte Corporation - Pipeline by Route of Administration, 2016
Incyte Corporation - Pipeline by Molecule Type, 2016
Incyte Corporation - Pipeline Products by Mechanism of Action, 2016
Incyte Corporation - Recent Pipeline Updates, 2016
Incyte Corporation - Dormant Developmental Projects,2016
Incyte Corporation - Discontinued Pipeline Products, 2016
Incyte Corporation, Subsidiaries
List of Figures
Incyte Corporation - Pipeline by Top 10 Indication, 2016
Incyte Corporation - Pipeline by Stage of Development, 2016
Incyte Corporation - Monotherapy Products in Pipeline, 2016
Incyte Corporation - Combination Treatment Modalities in Pipeline, 2016
Incyte Corporation - Partnered Products in Pipeline, 2016
Incyte Corporation - Out-Licensed Products in Pipeline, 2016
Incyte Corporation - Pipeline by Top 10 Target, 2016
Incyte Corporation - Pipeline by Route of Administration, 2016
Incyte Corporation - Pipeline by Molecule Type, 2016
Incyte Corporation - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report